172 related articles for article (PubMed ID: 38241547)
1. Prognostic value of cyclin B1 and cyclin B2 expression in breast cancer: A systematic review and updated meta-analysis.
Kang J; Jung H; Kim H
Medicine (Baltimore); 2024 Jan; 103(3):e37016. PubMed ID: 38241547
[TBL] [Abstract][Full Text] [Related]
2. CCNB2 expression correlates with worse outcomes in breast cancer patients: a pooled analysis.
Sun C; Lowe S; Ma S; Bentley R; Zhou Z; Cheng C; Zhou Q
Women Health; 2022 Aug; 62(7):655-663. PubMed ID: 35892137
[TBL] [Abstract][Full Text] [Related]
3. Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome.
Shubbar E; Kovács A; Hajizadeh S; Parris TZ; Nemes S; Gunnarsdóttir K; Einbeigi Z; Karlsson P; Helou K
BMC Cancer; 2013 Jan; 13():1. PubMed ID: 23282137
[TBL] [Abstract][Full Text] [Related]
4. Prognostic and clinicopathological significance of cyclin B expression in patients with breast cancer: A meta-analysis.
Sun X; Zhangyuan G; Shi L; Wang Y; Sun B; Ding Q
Medicine (Baltimore); 2017 May; 96(19):e6860. PubMed ID: 28489780
[TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of high/positive expression of cyclin B1 in patients with three common digestive cancers: a systematic review and meta-analysis.
Wen Y; Cao L; Lian WP; Li GX
Oncotarget; 2017 Nov; 8(56):96373-96383. PubMed ID: 29221213
[TBL] [Abstract][Full Text] [Related]
6. Strong expression of cyclin B2 mRNA correlates with a poor prognosis in patients with non-small cell lung cancer.
Takashima S; Saito H; Takahashi N; Imai K; Kudo S; Atari M; Saito Y; Motoyama S; Minamiya Y
Tumour Biol; 2014 May; 35(5):4257-65. PubMed ID: 24375198
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological and prognostic significance of cyclin D1 amplification in patients with breast cancer: a meta-analysis.
He Q; Wu J; Liu XL; Ma YH; Wu XT; Wang WY; An HX
J BUON; 2017; 22(5):1209-1216. PubMed ID: 29135104
[TBL] [Abstract][Full Text] [Related]
8. The prognostic role of tumor mutation burden on survival of breast cancer: a systematic review and meta-analysis.
Ke L; Li S; Cui H
BMC Cancer; 2022 Nov; 22(1):1185. PubMed ID: 36397030
[TBL] [Abstract][Full Text] [Related]
9. CDK1, CCNB1, and CCNB2 are Prognostic Biomarkers and Correlated with Immune Infiltration in Hepatocellular Carcinoma.
Zou Y; Ruan S; Jin L; Chen Z; Han H; Zhang Y; Jian Z; Lin Y; Shi N; Jin H
Med Sci Monit; 2020 Aug; 26():e925289. PubMed ID: 32863381
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients.
Zhao Z; Mu H; Li Y; Liu Y; Zou J; Zhu Y
Clin Transl Oncol; 2020 Oct; 22(10):1892-1906. PubMed ID: 32166713
[TBL] [Abstract][Full Text] [Related]
11. CCNB1 and CCNB2 involvement in the pathogenesis of psoriasis: a bioinformatics study.
Li AH; Chen YQ; Chen YQ; Song Y; Li D
J Int Med Res; 2022 Aug; 50(8):3000605221117138. PubMed ID: 35949173
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of cyclin D1 expression in colorectal cancer: a meta-analysis of observational studies.
Li Y; Wei J; Xu C; Zhao Z; You T
PLoS One; 2014; 9(4):e94508. PubMed ID: 24728073
[TBL] [Abstract][Full Text] [Related]
13. Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer.
Agarwal R; Gonzalez-Angulo AM; Myhre S; Carey M; Lee JS; Overgaard J; Alsner J; Stemke-Hale K; Lluch A; Neve RM; Kuo WL; Sorlie T; Sahin A; Valero V; Keyomarsi K; Gray JW; Borresen-Dale AL; Mills GB; Hennessy BT
Clin Cancer Res; 2009 Jun; 15(11):3654-62. PubMed ID: 19470724
[TBL] [Abstract][Full Text] [Related]
14. Prognostic and clinicopathological significance of SR-B1 in solid tumors: A meta-analysis.
Wang M; Chao C; Luo G; Wang B; Zhan X; Di D; Qian Y; Zhang X
Pathol Res Pract; 2020 Apr; 216(4):152849. PubMed ID: 32057516
[TBL] [Abstract][Full Text] [Related]
15. Cyclin B2 can compensate for Cyclin B1 in oocyte meiosis I.
Li J; Tang JX; Cheng JM; Hu B; Wang YQ; Aalia B; Li XY; Jin C; Wang XX; Deng SL; Zhang Y; Chen SR; Qian WP; Sun QY; Huang XX; Liu YX
J Cell Biol; 2018 Nov; 217(11):3901-3911. PubMed ID: 30097513
[TBL] [Abstract][Full Text] [Related]
16. Prognostic role of cyclin B1 in solid tumors: a meta-analysis.
Ye C; Wang J; Wu P; Li X; Chai Y
Oncotarget; 2017 Jan; 8(2):2224-2232. PubMed ID: 27903976
[TBL] [Abstract][Full Text] [Related]
17. Association between prognosis and SEMA4D/Plexin-B1 expression in various malignancies: A meta-analysis.
Yang Y; Wang J; Li H; Liu L; Yao M; Xiao T
Medicine (Baltimore); 2019 Feb; 98(7):e13298. PubMed ID: 30762724
[TBL] [Abstract][Full Text] [Related]
18. Expression of KIF2A, NDC80, CDK1, and CCNB1 in breast cancer patients: Their interaction and linkage with tumor features and prognosis.
Wang C; Xie X; Li W; Jiang D
J Clin Lab Anal; 2022 Sep; 36(9):e24647. PubMed ID: 35949045
[TBL] [Abstract][Full Text] [Related]
19. The Translation of Cyclin B1 and B2 is Differentially Regulated during Mouse Oocyte Reentry into the Meiotic Cell Cycle.
Han SJ; Martins JPS; Yang Y; Kang MK; Daldello EM; Conti M
Sci Rep; 2017 Oct; 7(1):14077. PubMed ID: 29074977
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of mitotic activity index (MAI), phosphohistone H3 (PPH3), cyclin B1, cyclin A, and Ki67, alone and in combinations, in node-negative premenopausal breast cancer.
Klintman M; Strand C; Ahlin C; Beglerbegovic S; Fjällskog ML; Grabau D; Gudlaugsson E; Janssen EA; Lövgren K; Skaland I; Bendahl PO; Malmström P; Baak JP; Fernö M
PLoS One; 2013; 8(12):e81902. PubMed ID: 24324728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
